Understanding Your TDEE on GLP-1: How Many Calories Do You Need?
TDEE (Total Daily Energy Expenditure) is the total number of calories your body burns in a day, including your BMR plus activity. On GLP-1 medication, understanding your TDEE helps ensure you are eating enough to preserve muscle and get adequate nutrition while still losing weight. Many GLP-1 patients actually eat too little.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Work with your healthcare provider or registered dietitian for personalized calorie targets.
TDEE Components
- BMR (60-70%): Calories burned at rest to maintain basic body functions
- TEF (8-15%): Thermic Effect of Food, calories burned digesting food. Higher protein diets increase TEF.
- EAT (5-10%): Exercise Activity Thermogenesis, calories burned during intentional exercise
- NEAT (15-30%): Non-Exercise Activity Thermogenesis, calories burned through daily movement, fidgeting, and posture
How GLP-1 Affects Each Component
- BMR: Decreases as you lose weight (smaller body = lower BMR)
- TEF: Decreases because you are eating less food overall
- EAT: May increase if you start exercising, or decrease if fatigue limits activity
- NEAT: Often decreases significantly on GLP-1 as reduced energy intake can lead to less unconscious movement. This is a major hidden factor in plateaus.
Calculating Your TDEE on GLP-1
Multiply your BMR by an activity factor:
- Sedentary (desk job, no exercise): BMR x 1.2
- Lightly active (1-3 days exercise/week): BMR x 1.375
- Moderately active (3-5 days exercise/week): BMR x 1.55
- Very active (6-7 days exercise/week): BMR x 1.725
For weight loss, eat 300-500 calories below your TDEE. GLP-1 medication naturally creates this deficit through appetite suppression, but tracking ensures you do not go too low.
Minimum Calorie Floors
Regardless of what TDEE calculations suggest, most experts recommend these minimum daily intakes on GLP-1:
- Women: At least 1200 calories per day
- Men: At least 1500 calories per day
- Active individuals: Add 200-400 calories above these minimums
If GLP-1 medication suppresses your appetite below these floors, you need to deliberately eat more calorie-dense, nutrient-rich foods to hit minimums.
Common TDEE Mistakes on GLP-1
- Not recalculating: Your TDEE drops as you lose weight. Recalculate every 15-20 pounds.
- Overestimating activity level: Be honest about your actual activity level
- Ignoring NEAT decline: If you are moving less unconsciously, your true TDEE may be 200-300 calories lower than calculated
- Eating too little: Many GLP-1 patients eat 800-1000 calories daily, which is unsustainably low and accelerates muscle loss
Start Your GLP-1 Journey with Trimi
Trimi helps you lose weight sustainably with medical support. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. Visit our treatment page to get started.
Frequently Asked Questions
Do I need to count calories on GLP-1?
Not necessarily. Most patients do well following hunger cues and focusing on protein targets. However, if you suspect you are eating too little (under 1200 calories) or have hit a plateau, tracking for a few days can reveal the issue.
How do I know if I am eating enough?
Signs you may be eating too little include persistent fatigue, hair loss, feeling cold, irritability, poor workout performance, and weight loss exceeding 3 pounds per week. If you experience these, deliberately increase calorie intake.
Does TDEE matter for maintenance after GLP-1?
Yes, critically. When you transition to maintenance, knowing your new TDEE helps you eat at the right level to maintain weight. Many patients regain weight because they return to pre-GLP-1 eating habits that exceed their now-lower TDEE.
More on Metrics & Tracking
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).